Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
1 June 2024
| m 04:03 | Nivolumab (Opdivo) diffhist +210 Jwarner talk contribs →Malignant pleural mesothelioma | ||||
| m 04:01 | Brentuximab vedotin (Adcetris) diffhist +134 Jwarner talk contribs →History of changes in PMDA indication | ||||
| m 03:50 | Pembrolizumab (Keytruda) diffhist +203 Jwarner talk contribs →Renal cell carcinoma | ||||
| m 03:43 | Cytarabine (Ara-C) diffhist +156 Jwarner talk contribs →History of changes in PMDA indication | ||||
|
|
m 03:26 | Stub 2 changes history +16,468 [Jwarner (2×)] | |||
| m |
|
03:26 (cur | prev) +504 Jwarner talk contribs →Regimens that contain experimental (unapproved) drugs | |||
| m |
|
03:25 (cur | prev) +15,964 Jwarner talk contribs →Regimens composed solely of approved drugs | |||
28 May 2024
| m 23:12 | Allogeneic HSCT diffhist +605 Jwarner talk contribs →References | ||||
26 May 2024
| m 12:55 | Rituximab (Rituxan) diffhist -13 Jwarner talk contribs →Also known as | ||||
25 May 2024
| m 11:09 | Complex multipart regimens diffhist -1,458 Jwarner talk contribs →PRONOUNCE | ||||
23 May 2024
|
|
m 11:59 | How I Treat 2 changes history +237 [Jwarner (2×)] | |||
| m |
|
11:59 (cur | prev) +1 Jwarner talk contribs →=Acute respiratory failure | |||
| m |
|
11:58 (cur | prev) +236 Jwarner talk contribs →Atrial fibrillation | |||
20 May 2024
| m 13:28 | Study Groups diffhist -1 Jwarner talk contribs →Main table | ||||
18 May 2024
|
|
m 01:20 | Autologous HSCT 2 changes history +226 [Jwarner (2×)] | |||
| m |
|
01:20 (cur | prev) +146 Jwarner talk contribs | |||
| m |
|
00:51 (cur | prev) +80 Jwarner talk contribs | |||
17 May 2024
15 May 2024
| m 11:33 | Hodgkin lymphoma, nodular lymphocyte-predominant diffhist -7 Warner-admin talk contribs Text replacement - "*<big>We have moved How I Treat articles to a dedicated page.</big>" to "*''We have moved How I Treat articles to a dedicated page.''" | ||||
14 May 2024
| m 00:31 | Allogeneic HSCT diffhist +71 Jwarner talk contribs | ||||
|
|
m 00:29 | Autologous HSCT 2 changes history +114 [Jwarner (2×)] | |||
| m |
|
00:29 (cur | prev) +63 Jwarner talk contribs | |||
| m |
|
00:28 (cur | prev) +51 Jwarner talk contribs | |||
13 May 2024
| m 13:39 | Study Groups diffhist +4 Jwarner talk contribs →Main table | ||||
| m 00:03 | Complex multipart regimens diffhist -2,386 Jwarner talk contribs →CALGB 9741 | ||||
7 May 2024
| m 14:43 | Classical Hodgkin lymphoma - historical diffhist +108 Jwarner talk contribs →NOVP {{#subobject:230457|Regimen=1}} | ||||
| m 12:06 | Classical Hodgkin lymphoma, pediatric diffhist -9 Jwarner talk contribs →NCCN | ||||
6 May 2024
| m 23:52 | Hodgkin lymphoma, nodular lymphocyte-predominant diffhist +3 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/hodgkins.pdf" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1439" | ||||
3 May 2024
|
|
m 23:53 | Classical Hodgkin lymphoma - historical 5 changes history +2,810 [Jwarner (5×)] | |||
| m |
|
23:53 (cur | prev) +314 Jwarner talk contribs →ABVD {{#subobject:c5a35d|Regimen=1}} | |||
| m |
|
23:49 (cur | prev) +70 Jwarner talk contribs →NOVP {{#subobject:230457|Regimen=1}} | |||
| m |
|
23:44 (cur | prev) +478 Jwarner talk contribs →COPP/ABVD {{#subobject:92a2c8|Regimen=1}} | |||
| m |
|
20:28 (cur | prev) +1,399 Jwarner talk contribs →Untreated | |||
| m |
|
19:58 (cur | prev) +549 Jwarner talk contribs →COPP/ABVD {{#subobject:92a2c8|Regimen=1}} | |||